Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2021 | Series B | $103M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Highside Capital Management | — | Series B |